60 related articles for article (PubMed ID: 3955556)
1. Phase II trial of aminothiadiazole in advanced non-small cell lung cancer.
Shevrin DH; McGuire WP; Lanzotti V; Krauss S; Blough R; Cobleigh M; Johnson C; Lad T; Kukla L
Cancer Treat Rep; 1986 Mar; 70(3):417-8. PubMed ID: 3955556
[No Abstract] [Full Text] [Related]
2. Phase II trial of anaxirone in advanced non-small cell lung cancer.
Fiebig HH; Henss H; Arnold H; von Bültzingslöwen F; Klee M; Queisser W; Peukert M
Cancer Treat Rep; 1987 May; 71(5):539-40. PubMed ID: 3567979
[No Abstract] [Full Text] [Related]
3. Phase II trial of carboplatin in non-small cell lung cancer.
Olver IN; Donehower RC; Van Echo DA; Ettinger DS; Aisner J
Cancer Treat Rep; 1986 Mar; 70(3):421-2. PubMed ID: 3513947
[No Abstract] [Full Text] [Related]
4. Aminothiadiazole: an antineoplastic thiadiazole.
O'Dwyer PJ; Wagner BH; Stewart JA; Leyland-Jones B
Cancer Treat Rep; 1986 Jul; 70(7):885-9. PubMed ID: 2872957
[No Abstract] [Full Text] [Related]
5. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Conley BA; Hornedo J; Abrams J; Eisenberger M; Hiponia D; Aisner J; Van Echo DA
Cancer Treat Rep; 1987 Sep; 71(9):861-2. PubMed ID: 3040246
[No Abstract] [Full Text] [Related]
7. Phase II trial of AMSA in patients with refractory small cell carcinoma of the lung.
Fuks JZ; Van Echo DA; Aisner J; Von Hoff D; Wiernik PH
Cancer Treat Rep; 1981; 65(1-2):133-4. PubMed ID: 6261947
[No Abstract] [Full Text] [Related]
8. Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
Asbury RF; Blessing JA; DiSaia PJ; Malfetano J
Am J Clin Oncol; 1989 Oct; 12(5):375-7. PubMed ID: 2801597
[TBL] [Abstract][Full Text] [Related]
9. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group.
Asbury RF; Blessing JA; Mortel R; Homesley HD; Malfetano J
Am J Clin Oncol; 1987 Aug; 10(4):299-301. PubMed ID: 3618541
[TBL] [Abstract][Full Text] [Related]
10. Phase II evaluation of triazinate in patients with metastatic lung cancer.
Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
[No Abstract] [Full Text] [Related]
11. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
Myers JW; Von Hoff DD; Clark GM; Coltman CA
Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
[No Abstract] [Full Text] [Related]
12. Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.
Bertrand M; Multhauf P; Presant C; Rappaport D; Blayney DW; Carr BI; Cecchi G; Doroshow JH; Emont E; Goldberg D
Cancer Treat Rep; 1985 Nov; 69(11):1335-6. PubMed ID: 4092199
[No Abstract] [Full Text] [Related]
13. A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.
Marks RS; Graham DL; Sloan JA; Hillman S; Fishkoff S; Krook JE; Okuno SH; Mailliard JA; Fitch TR; Addo F
Am J Clin Oncol; 2003 Aug; 26(4):336-7. PubMed ID: 12902880
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.
Kaplan S; Sessa C; Joss R; Obrecht JP; Siegenthaler P; Cavalli F
Cancer Treat Rep; 1985 Nov; 69(11):1337-8. PubMed ID: 4092200
[No Abstract] [Full Text] [Related]
15. Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group.
Asbury RF; Wilson J; Blessing JA; Buchsbaum HJ; DiSaia PJ
Am J Clin Oncol; 1986 Aug; 9(4):334-6. PubMed ID: 3751971
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.
Lynch GR; Gralla RJ; Kelsen DP; Casper ES; Stoopler MB; Golbey RB
Cancer Clin Trials; 1981; 4(3):273-6. PubMed ID: 6974611
[TBL] [Abstract][Full Text] [Related]
17. Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group.
Asbury RF; Kramar A; Haller DG
Am J Clin Oncol; 1987 Oct; 10(5):380-2. PubMed ID: 3661489
[TBL] [Abstract][Full Text] [Related]
18. High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial.
Locker GY; Kilton L; Khandekar JD; Lad TE; Knop RH; Albain K; Blough R; French S; Benson AB
Invest New Drugs; 1994; 12(4):299-301. PubMed ID: 7775130
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma.
Feld R; Evans WK; Shepherd FA; Deboer G; Ottema B
Cancer Treat Rep; 1985 Feb; 69(2):209-10. PubMed ID: 3971392
[TBL] [Abstract][Full Text] [Related]
20. [Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer].
Xu RH; Guan ZZ; Jiang WQ; Huang H; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C; Ma ZY; Wang JH
Ai Zheng; 2002 Dec; 21(12):1354-8. PubMed ID: 12520747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
